Deborah completed her PhD with highest honours in 2019 from the University of Paris-Saclay, France. Her studies concentrated on modelling Neurofibromatosis type 1 using pluripotent stem cells-derived Schwann cells at ISTEM (Institute for Stem cell Therapy and Exploration of Monogenic diseases). After completing her PhD, Deborah joined one of France's most prestigious research establishments, the College-de-France Institute, working for Prof. Alain Prochiantz’s group. Her post-doctoral research investigated Amyotrophic Lateral Sclerosis (ALS) pathophysiology using human iPSC-derived motorneurons.
In January 2022, Deborah joined with enthusiasm the Stem Cell Medicine Group as a research officer under the lead of Dr. Anai Gonzalez Cordero. Benefiting from iPSC-derived retinal organoids She works on modelling the most common inherited deaf-blinding disease, Usher type 2a. Her overall aim is to develop new genetic therapies.
In her spare time, she is discovering the city of Sydney, and loves hiking and outdoor activities, but she also enjoys doing lots of craft activities at home when the sun is not out.